Utah Medical Products - 20 Year Stock Price History | UTMD

Historical daily share price chart and data for Utah Medical Products since 1999 adjusted for splits. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for Utah Medical Products as of March 18, 2019 is 83.72.
Utah Medical Products Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 88.4535 84.7700 99.2000 83.2200 83.7200 0.77%
2018 93.7483 78.3972 115.3033 74.6400 83.0800 3.24%
2017 68.3776 69.5329 83.0931 57.3110 80.4733 13.59%
2016 60.8573 56.2062 70.8476 53.1880 70.8476 26.31%
2015 53.6074 54.4561 59.2326 48.0506 56.0912 -0.72%
2014 49.3399 47.7972 56.5730 43.6797 56.4977 7.04%
2013 45.6233 34.6892 58.2887 34.6892 52.7838 61.74%
2012 29.0973 24.0157 32.7338 23.7255 32.6343 37.45%
2011 23.1225 22.9034 25.0860 21.1792 23.7431 4.07%
2010 22.2637 23.6455 24.8263 19.8901 22.8143 -2.73%
2009 20.4847 18.4902 23.8080 16.4619 23.4535 38.40%
2008 20.9530 22.0891 23.0593 16.3339 16.9461 -23.59%
2007 23.3352 23.9425 25.1839 21.7938 22.1787 -7.31%
2006 22.6023 21.6638 24.8749 20.1770 23.9280 5.78%
2005 16.5458 15.3164 22.6195 13.8613 22.6195 45.97%
2004 15.7167 17.3730 18.3499 11.7304 15.4957 -12.27%
2003 14.3080 13.0483 17.6636 11.8253 17.6636 36.86%
2002 10.5882 8.9196 13.0281 8.4736 12.9064 40.34%
2001 7.1091 5.0680 9.2845 4.7511 9.1967 81.47%
2000 4.8475 4.3517 5.6592 4.0544 5.0680 11.11%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.323B $0.042B
Utah Medical Products is in the business of producing cost-effective devices for the healthcare industry which are predominantly proprietary, disposable and for hospital use. The company's success in rapidly producing solutions comes from its proven ability to integrate a number of engineering and technical disciplines in electronics, software, mechanical packaging, instrumentation, optics and materials. The resulting proprietary products represent significant incremental improvementsover existing clinical techniques.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $140.272B 27.73
Medtronic (MDT) Ireland $125.787B 18.39
Stryker (SYK) United States $72.312B 26.54
Boston Scientific (BSX) United States $55.730B 27.17
Baxter (BAX) United States $39.435B 25.23
Zimmer Biomet Holdings (ZBH) United States $25.742B 16.48
Smith & Nephew SNATS (SNN) United Kingdom $17.346B 0.00
Canopy Growth (CGC) Canada $15.357B 0.00
ResMed (RMD) United States $14.383B 27.27
Aurora Cannabis (ACB) Canada $9.728B 68.64
Bio-Rad Laboratories (BIO) United States $9.298B 53.05
Hill-Rom Holdings (HRC) United States $6.949B 21.49
Perrigo (PRGO) Ireland $6.542B 10.61
Insulet (PODD) United States $5.812B 1960.80
GW Pharmaceuticals (GWPH) United Kingdom $5.107B 0.00
ICU Medical (ICUI) United States $4.771B 29.70
Haemonetics (HAE) United States $4.422B 39.23
Agios Pharmaceuticals (AGIO) United States $3.796B 0.00
Hutchison China MediTech (HCM) China $3.712B 0.00
Neogen (NEOG) United States $3.240B 49.77
NuVasive (NUVA) United States $2.859B 24.94
Quidel (QDEL) United States $2.688B 24.25
Aphria (APHA) $2.403B 106.67
National Vision Holdings (EYE) United States $2.385B 46.92
Cardiovascular Systems (CSII) United States $1.382B 992.25
Phibro Animal Health (PAHC) United States $1.275B 18.33
VAREX IMAGING (VREX) United States $1.255B 24.57
AtriCure (ATRC) United States $1.121B 0.00
MacroGenics (MGNX) United States $0.933B 0.00
Lantheus Holdings (LNTH) United States $0.929B 25.10
NanoString Technologies (NSTG) United States $0.855B 0.00
Cerus (CERS) United States $0.838B 0.00
PetIQ (PETQ) United States $0.787B 22.53
Omeros (OMER) United States $0.786B 0.00
OraSure Technologies (OSUR) United States $0.721B 31.62
Surmodics (SRDX) United States $0.703B 102.18
Meridian Bioscience (VIVO) United States $0.701B 20.89
Evolus (EOLS) United States $0.677B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.655B 22.28
LeMaitre Vascular (LMAT) United States $0.614B 29.22
TG Therapeutics (TGTX) United States $0.607B 0.00
Quanterix (QTRX) United States $0.552B 0.00
BioLife Solutions (BLFS) United States $0.346B 143.85
Vapotherm (VAPO) United States $0.335B 0.00
Insys Therapeutics (INSY) United States $0.308B 0.00
Owens & Minor (OMI) United States $0.301B 4.17
Rockwell Medical (RMTI) United States $0.297B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.269B 0.00
Bovie Medical (APYX) United States $0.263B 0.00
Cytosorbents (CTSO) United States $0.255B 0.00
Fonar (FONR) United States $0.146B 7.81
Zynex (ZYXI) United States $0.142B 15.14
Surface Oncology (SURF) United States $0.131B 0.00
Chimerix (CMRX) United States $0.104B 0.00
Chembio Diagnostics (CEMI) United States $0.101B 0.00
Female Health (VERU) United States $0.094B 0.00
United-Guardian (UG) United States $0.089B 18.64
Conatus Pharmaceuticals (CNAT) United States $0.081B 0.00
Trinity Biotech (TRIB) Ireland $0.073B 21.79
CAS Medical Systems (CASM) United States $0.072B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.056B 0.00
Neurotrope (NTRP) United States $0.052B 0.00
Valeritas Holdings (VLRX) United States $0.039B 0.00
ImmuCell (ICCC) United States $0.037B 0.00
Senestech (SNES) United States $0.026B 0.00
Capricor Therapeutics (CAPR) United States $0.016B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.015B 0.00
Akers Biosciences Inc (AKER) United States $0.013B 0.00
Cellectar Biosciences (CLRB) United States $0.011B 0.00
NeuroMetrix (NURO) United States $0.008B 15.14